Tricuspid annuloplasty in ischemic cardiomyopathy patients undergoing restrictive mitral annuloplasty
Yusuke Misumi(The University of Osaka), Shigeru Miyagawa(The University of Osaka), Shin Yajima(National Cerebral and Cardiovascular Center), Ai Kawamura(The University of Osaka), Takashi Yamauchi(Asahikawa Medical College Hospital), Takuji Kawamura(The University of Osaka), Satoshi Kainuma(National Cerebral and Cardiovascular Center), Daisuke Yoshioka(The University of Osaka), Masaki Taira(The University of Osaka), Kazuo Shimamura(The University of Osaka), Shunsuke Saito(The University of Osaka)
Cited by 0
Related Papers
Brain 14‐3‐3 protein is an activator protein that activates tryptophan 5‐monooxygenase and tyrosine 3‐monooxygenase in the presence of Ca<sup>2+</sup>,calmodulin‐dependent protein kinase II
|FEBS Letters|1987|293
Molecular constituents of the postsynaptic density fraction revealed by proteomic analysis using multidimensional liquid chromatography‐tandem mass spectrometry
|Journal of Neurochemistry|2003|211
Case report: Transplantation of human induced pluripotent stem cell-derived cardiomyocyte patches for ischemic cardiomyopathy
|Frontiers in Cardiovascular Medicine|2022|106
IL-4 as a Repurposed Biological Drug for Myocardial Infarction through Augmentation of Reparative Cardiac Macrophages: Proof-of-Concept Data in Mice
|Scientific Reports|2017|105
2023 National Clinical Database Annual Report by the Japan Surgical Society
|Surgery Today|2025|79